Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers
NCT01043003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2015-06-08
Summary
RATIONALE: Studying quality-of-life in patients having cancer treatment may identify the intermediate- and long-term effects of treatment on patients with cancer
PURPOSE: This randomized clinical trial is studying how well an educational intervention works in supporting Hispanic women with stage I, stage II, or stage III breast cancer and their families or caregivers.
Conditions
- Breast Cancer
- Ductal Breast Carcinoma in Situ
- Stage I Breast Cancer
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
Interventions
- OTHER
-
educational intervention
Undergo Bilingual Breast Cancer Educational Intervention
- PROCEDURE
-
quality-of-life assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
psychosocial support for caregiver
Support for caregiver
- PROCEDURE
-
assessment of therapy complications
Ancillary study
- OTHER
-
informational intervention
Undergo evaluation sessions
Sponsors & Collaborators
-
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Gloria Juarez · City of Hope Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2011-11-30
- Completion
- 2011-11-30
Countries
- United States
Study Locations
More Related Trials
-
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
NCT04293393 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
NCT04297384 ·Status: COMPLETED ·Phase: NA
-
Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
NCT03123263 ·Status: COMPLETED
-
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
NCT05901428 ·Status: RECRUITING ·Phase: PHASE3
-
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
NCT06348134 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
NCT07043725 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients
NCT05755581 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
NCT00014222 ·Status: COMPLETED ·Phase: PHASE3
-
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
NCT06260033 ·Status: RECRUITING ·Phase: PHASE2
-
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
NCT06763328 ·Status: RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
NCT00004092 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.
NCT07136974 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer
NCT01093612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
NCT02789657 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
NCT04052555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
NCT02041351 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
NCT00072319 ·Status: COMPLETED ·Phase: PHASE2
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
NCT00002873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer
NCT02535221 ·Status: RECRUITING ·Phase: PHASE3
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
NCT05020860 ·Status: RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
NCT00003927 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer
NCT07246317 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
NCT00545688 ·Status: COMPLETED ·Phase: PHASE2